This inventor holds 4 USPTO granted patents and 1 EPO patent. Top assignees: Cytochroma Development Inc., Ineos Healthcare Limited, Ineos Silicas Limited. Active years: 2005-2016.
Company Filing History:
1 out of 2 
1 out of 1 
1 out of 5 
Years Active: 2005-2016
Title: The Innovations of Norman Bryson Roberts
Introduction
Norman Bryson Roberts is a notable inventor based in Liverpool, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of metal compounds for medical use. With a total of four patents to his name, Roberts has focused on creating innovative solutions for health-related issues.
Latest Patents
Roberts' latest patents include advancements in metal compounds mixed or sulphated, which serve as phosphate binders. These mixed metal compounds are free from aluminum and possess a phosphate binding capacity of at least 30% by weight of the total phosphate present, across a pH range of 2-8. This innovation is particularly beneficial for the treatment of hyperphosphataemia. The preferred metals used in these compounds include iron (III) along with calcium, magnesium, lanthanum, and cerium. Additionally, he has developed metal sulphates for pharmaceutical use, selected from calcium, lanthanum, and cerium sulphate compounds, which also demonstrate a phosphate binding capacity of at least 30% by weight.
Career Highlights
Throughout his career, Norman Bryson Roberts has worked with prominent companies such as Ineos Silicas Limited and Ineos Healthcare Limited. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in pharmaceutical applications.
Collaborations
Some of his notable coworkers include Maurice Webb and Benjamin Joseph Rankin. Their collaboration has likely fostered an environment of creativity and innovation, leading to the development of impactful pharmaceutical solutions.
Conclusion
Norman Bryson Roberts stands out as a significant figure in the field of pharmaceutical inventions. His work on metal compounds as phosphate binders showcases his commitment to improving health outcomes through innovation.